Gastric Botox: What It Does and What It Does Not Do

Gastric botox is one of the most heavily marketed weight-loss procedures aimed at medical travellers, and also one of the most poorly understood. It is sold as a quick, needle-free, incision-free alternative to bariatric surgery: no cutting, no stapling, home the same day. What is rarely explained with the same enthusiasm is what the published evidence says about whether it works, how long any effect lasts, and what happened in 2023 when a cluster of serious poisonings across Europe was traced back to this exact procedure.

This guide sets out what gastric botox is, what it is designed to do, and — just as importantly — what it does not do. If you are weighing it against a balloon or against an operation, the comparison matters more than the sales page. You can read what we offer on our gastric botox in Turkey page, but read this first.

What gastric botox actually is

Gastric botox is an endoscopic injection of botulinum neurotoxin type A into the muscular wall of the stomach. There is no incision and no change to the shape or plumbing of the digestive tract. An endoscope is passed through the mouth into the stomach, and the toxin is injected at several points in the stomach wall — most commonly in the antrum, the lower part of the stomach that grinds food and pushes it onward, and in some protocols also in the fundus and body.

The substance itself is the same class of medicine used cosmetically and for a range of medical conditions. Mayo Clinic describes its action simply: botulinum toxin injections block the chemical signals from nerves that make muscles contract, keeping the muscle still for a limited period. Its established uses include cervical dystonia, muscle spasticity, hyperhidrosis, chronic migraine and overactive bladder, as well as the cosmetic use most people know it by.

Weight loss is not on that list. That single fact shapes everything else in this guide.

How it is supposed to work

The theory is reasonable on paper. If the muscle of the stomach wall is partially relaxed, the stomach empties more slowly. Food stays in the stomach longer, stretch receptors keep signalling fullness, and the person eats less at each meal and goes longer between meals. Reduce intake over several months and weight comes off.

That is a hypothesis about mechanism, not a demonstrated clinical outcome, and the two are easy to conflate. Plenty of interventions slow gastric emptying without producing meaningful or durable weight loss, because appetite is governed by hormones, habit, sleep, stress and reward pathways as much as by stomach volume. A mechanical slowdown addresses one input among many.

What happens on the day

The procedure is short. It is performed under sedation, usually takes between fifteen and forty-five minutes depending on how many injection sites the protocol calls for, and most people go home the same day. You will be asked to fast beforehand so the stomach is empty and the injection sites are visible.

Afterwards, nausea, bloating, mild upper abdominal discomfort and indigestion are commonly reported in the days that follow. Because the stomach is deliberately being slowed, a feeling of heaviness after eating is expected rather than surprising. Most clinics pair the injection with a calorie-restricted eating plan and follow-up appointments, which matters a great deal when you come to interpret the results — more on that below.

What the published evidence actually shows

This is where the marketing and the literature part company. A review of the published studies led by researchers at Weill Cornell Medicine-Qatar with Hamad Medical Corporation, published in Obesity Surgery, looked at both clinical trials and case-based reports of endoscopic intragastric botulinum toxin for obesity. Their conclusions were blunt.

Some studies did report weight loss and earlier fullness at around one month.
By three to six months, most patients had regained the weight, weighed more than before, or had lost only a minimal amount.
Trials that compared the injection against a saline placebo found little difference in appetite, weight or fullness between the two groups.
The one trial that did show significant total weight loss also placed every participant on a very low-calorie liquid diet for eight weeks — making it impossible to attribute the result to the injection.
The overall quality of the available studies was judged to be poor.

The lead author stated that the team found no compelling evidence for the use of botulinum injections into the stomach as a treatment for obesity, and the senior author concluded that it is not to be recommended as an obesity treatment. Other systematic reviews and meta-analyses have reached mixed conclusions, with some reporting a benefit in selected groups; what they share is small sample sizes, short follow-up and inconsistent injection protocols — different doses, different sites, different numbers of injections. When the protocol itself is not standardised, “gastric botox” is not one treatment being tested repeatedly, but a family of loosely related ones.

That placebo comparison deserves to sit in the front of your mind. If a saline injection produces much the same appetite change as the toxin, then the clinic appointment, the pre-procedure fast, the supervised diet and the follow-up calls may be doing the work that the injection is being credited with.

The effect is temporary by design

Botulinum toxin does not permanently alter a muscle. Nerve signalling recovers, and the muscle returns to its previous behaviour. Mayo Clinic notes that depending on the condition being treated, the effect of an injection may last around three to four months, and that maintaining it requires repeat injections. The obesity review cited above found that the effect on the stomach wears off within three to six months.

So the honest framing is not “a non-surgical alternative to a sleeve” but “a temporary change that reverses itself within a few months.” Any weight lost during that window has to be held afterwards by eating habits alone, with the stomach behaving exactly as it did before. This is the opposite of what a permanent anatomical change does, for better and for worse: surgery is irreversible and carries operative risk, but it does not expire.

Off-label use: what the term means here

Medicines are licensed for specific indications after review by a regulator. Using a licensed medicine outside those indications is called off-label use. It is lawful and sometimes entirely appropriate — doctors do it routinely where experience and evidence support it — but it means the regulator has not assessed the dose, the route or the safety profile for that purpose.

The European Centre for Disease Prevention and Control, the EU public health agency, stated plainly in its reporting on the 2023 cases that although licensed botulinum neurotoxin products were used, these products are not approved for the treatment of obesity by intragastric injection. There is therefore no regulator-sanctioned dose for the stomach. The quantity injected is a matter of local protocol, and protocols vary between clinics and between countries.

The 2023 botulism outbreak in Türkiye

This is the part of the story that no honest guide to gastric botox can omit, and it is the single strongest reason to approach the procedure carefully.

Between late February and the end of March 2023, ECDC reported 87 cases of botulism linked to intragastric botulinum neurotoxin injections given for obesity: 53 in Türkiye, 30 in Germany, 2 in Switzerland, 1 in France and 1 in Austria. The treatments had been given between 3 February and 1 March 2023 at two private hospitals, one in Istanbul and one in Izmir. Symptoms ranged from mild to severe; several patients were hospitalised, some required intensive care, and some were given botulinum antitoxin. The relevant hospital departments were suspended and investigations were opened. ECDC noted that German patients had received doses in the range of 1,000 to 2,500 units, and said it was not clear whether the cause lay in a clinical or procedural failure or in the product itself.

ECDC’s advice at the time was unambiguous: it strongly encouraged EU and EEA citizens to avoid intragastric treatments with botulinum neurotoxin for obesity in Türkiye, describing the treatment as carrying a significant risk of botulism, and advised anyone who had travelled for it in the relevant window to seek medical advice, particularly if they developed weakness or difficulty breathing or swallowing.

Two things need saying about this, and both are true. The first is that the outbreak was traced to a specific window and specific facilities, not to every clinic in the country — and a documented cluster is not the same as an ongoing one. The second is that the mechanism of harm is real and inherent to the procedure rather than incidental to it: botulinum toxin injected into a well-supplied muscular organ can spread systemically, and Mayo Clinic’s general guidance on botulinum injections warns that the medicine may rarely spread beyond the treatment site, with muscle weakness, vision changes, difficulty speaking or swallowing, and breathing problems as warning signs that require immediate medical attention. A high dose in a large organ is not a trivial version of a cosmetic injection.

If you are considering this procedure, the sensible step is to check the current travel health advice issued by your own national health authority rather than relying on a clinic’s reassurance or on what was true in any given year.

What gastric botox does not do

Set against the way it is advertised, the list of things gastric botox does not do is long.

It does not reduce the size of the stomach. Nothing is removed, stapled, divided or banded. The stomach’s capacity is unchanged.
It does not change gut hormones the way surgery does. The hormonal and metabolic shifts that follow a sleeve or a bypass come from altering or removing tissue, not from relaxing muscle.
It does not treat type 2 diabetes. Metabolic improvement is a recognised effect of bariatric surgery, and there is no comparable evidence base for a temporary injection.
It does not last. See above.
It is not a substitute for an operation if you meet the criteria for one, and it is not a stepping stone that makes later surgery easier.
It does not remove the need to change how you eat. Every protocol that reports any result pairs the injection with calorie restriction.

It is worth being equally clear about what it is not: it is not a scam in the sense of being a fiction. It is a real intervention with a plausible mechanism, a short duration of action, an evidence base too weak to support the claims made for it, and a safety signal that has caused serious harm when dosing or technique went wrong.

How it sits against the alternatives

If what appeals to you about gastric botox is avoiding surgery, the comparison worth making is with the other temporary, endoscopic option rather than with an operation. We have set the balloon against the sleeve in a separate guide, and the balloon has something gastric botox does not: a device that physically occupies space, a defined removal date, and a larger and more consistent body of published outcomes behind it.

If your weight and health picture is the kind that bariatric teams treat surgically, the honest comparison is with a sleeve or a bypass. ASMBS describes five endorsed procedures — sleeve gastrectomy, Roux-en-Y gastric bypass, adjustable gastric band, biliopancreatic diversion with duodenal switch, and SADI-S — and is explicit that lasting results from any of them depend on lifelong changes in eating and activity plus continued follow-up and periodic blood tests. Our gastric sleeve and gastric balloon pages describe what each involves here.

Before any of that, the first question is whether you meet the criteria at all. Our guide on whether you are a candidate covers the thresholds teams actually use, and our guide to the risks and complications of surgery gives you the other side of that ledger honestly.

Questions worth asking before you book

If you decide to go ahead, the questions below are the ones that separate a careful service from a careless one. Our fuller list of questions to ask your surgeon and our guide to choosing a hospital abroad apply here too.

What product is being used, what dose in total units, and at how many sites?
Who performs the endoscopy, and what are their credentials in endoscopy specifically?
What is the facility’s protocol if I develop weakness, double vision, or difficulty swallowing or breathing after I fly home?
Is botulinum antitoxin available, and where is the nearest unit that can manage botulism?
What exactly is being claimed about weight loss, over what period, and on what published evidence?
What is the dietary programme that comes with it, and who supervises it?
What happens at month four, when the effect wears off?

That last question is the important one. If the answer is “a repeat injection”, you are being offered an open-ended series of off-label procedures rather than a treatment with an endpoint.

What the evidence does support

None of this means there is nothing to be done. The interventions with real evidence behind them are less exciting and more effective: structured dietary change, physical activity, obesity medications prescribed and monitored properly, and — for people who meet the criteria — bariatric surgery, which has decades of outcome data. Whatever route you take, how you eat afterwards does most of the long-term work, which is why our guide to eating after bariatric surgery is the most-read thing we publish, and why teams ask patients to follow a pre-operative diet before an operation at all.

If you want a realistic picture of outcomes rather than a promise, our guide to how much weight people actually lose and our walk-through of the day of surgery are a better starting point than any procedure’s marketing page. Practical preparation is covered in what to pack, and the full library is indexed in our guides section.

We do offer this procedure, and you can read about it on our gastric botox page. We would rather you arrived at that decision having read the evidence than having read a brochure.

Frequently asked questions

Does gastric botox actually cause weight loss?

The published evidence does not support a confident yes. Reviews of the literature have found weight loss reported at around one month, with most of it regained by three to six months, and trials using a saline placebo found little difference between groups. Where significant loss was reported, a very low-calorie diet was running alongside the injection. The quality of the studies is generally poor.

How long does it last?

The effect on the stomach wears off within three to six months according to the obesity literature; botulinum injections generally last around three to four months depending on the indication. There is no version of this procedure that is permanent.

Is it approved for weight loss?

No. ECDC stated that the licensed botulinum neurotoxin products involved in the 2023 cases are not approved for the treatment of obesity by intragastric injection. Its use for this purpose is off-label, which means no regulator has assessed the dose or route for the stomach.

Is it safe?

The common effects are nausea, bloating and injection-site discomfort. The serious risk is systemic spread of the toxin, which can cause muscle weakness, difficulty swallowing or speaking, vision changes and, in severe cases, breathing failure requiring ventilation. ECDC documented 87 botulism cases in 2023 linked to this procedure at two private hospitals in Türkiye, with some patients needing intensive care. That risk is dose- and technique-dependent, not theoretical.

Is it a good first step before surgery?

There is no evidence that it makes later surgery safer or easier, and it does not change the stomach in any way that persists. If you meet the criteria for an operation, the question is which operation, not whether to try an injection first.

Can I have it instead of a balloon?

Both are temporary and endoscopic, but the balloon has a device that physically occupies space, a scheduled removal, and a more consistent published record. If you are choosing between non-surgical options, that difference is worth weighing rather than assuming they are equivalent.

What should I do if I feel unwell after having it abroad?

Seek medical advice without delay, and say explicitly that you have had botulinum toxin injected into your stomach — it changes the differential diagnosis completely. Weakness, drooping eyelids, double vision, slurred speech, and difficulty swallowing or breathing are the symptoms that need urgent assessment, and they can appear days or weeks after the procedure.

Related guides

Sources and a note on this guide

The clinical statements above draw on published guidance and peer-reviewed review work: the European Centre for Disease Prevention and Control update on iatrogenic botulism cases in Europe and its report on botulism following medical interventions with botulinum neurotoxin; the Weill Cornell Medicine-Qatar and Hamad Medical Corporation review of endoscopic intragastric botulinum toxin-A for obesity; Mayo Clinic on botulinum toxin injections; and the American Society for Metabolic and Bariatric Surgery summary of endorsed procedures.

This article is general information, not medical advice. It cannot account for your medical history, your medications or your individual risk, and it is not a substitute for assessment by a qualified clinician. If you are considering any weight-loss procedure, discuss it with a doctor who has examined you, and check the current travel health guidance issued by your own national health authority. Where the instructions of your own surgical or medical team differ from anything written here, follow your team.